/PRNewswire/ In the near future, the leukapheresis industry is poised for remarkable growth and transformation, driven by advancements in medical technology.
The Continuous Renal Replacement Therapy Market Revenue is predicted to grow from US$ 1,214.6 billion in 2023 to US$ 2,771.6 billion in 2033. During the forecast period, the market is expected to grow at an 8.6% CAGR. In contrast to standard renal replacement therapies such as IHD, which take 4-6 hours, this therapy.
According to the new market research report Published by MarketsandMarkets, Continuous Renal Replacement Therapy Market by Product (Disposables (Hemofilters,
/PRNewswire/ The "Global Renal Replacement Therapy Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com s offering. The.